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Primaclone (P) is a drug used in the
management of seizures in humans and
dogs. Because ofwidespread human use,
the in vivo conversion ofprimaclone to
phenobarbital, and the lack ofreproductive
data in the open literature, primadone was
tested for potential effects on reproduction
and fertility in Swiss CD-1 mice using the
RACB protocol. The dose-range-finding
study (Task 1) for this study utilized a sin-
gle mating trial and delivery, since the lit-
erature indicated that excessive P reduced
early neonatal survival. Pup survival was
found to be reduced at 0.2% P. These pup
data were used in conjunction with data
on food and water consumptions, body
weights, and clinical signs, to set exposure
concentrations for the continuous cohabita-
tion phase (Task 2) 0.015, 0.05, and 0.15%
weight per volume in feed. Body weights of
Fo mice were not reduced during Task 2,
and feed consumption was not changed by
P addition. With measures ofbody weights
and feed consumption, calculated daily
exposure estimates were approximately 24,
80, and 235 mg/kg/day. Second generation
estimates were similar.
During Task 2, of 80 mice per group,
one, three, zero, and three mice died in the
control to high dose groups, respectively.
These deaths were attributed to a variety of
causes with no consistent pattern, and were
notjudged to be treatment related.
Primaclone consumption did not affect
the mean number oflitters delivered per
pair, the number oflive pups per litter, or
the viability or pup weight adjusted for lit-
ter size ofthose pups. In short, there were
no indications of reproductive toxicity
observed during Task 2.
In the absence ofreproductive toxicity,
the last litter from all dose levels was reared
by the dam until weaning. There were no
treatment-related reductions in pup body
weight gain or in viability during the nurs-
ing period. At weaning, the low and mid-
dle dose groups were killed and discarded,
and the controls and high dose mice reared
on the same concentrations ofP consumed
by their parents until mating at 74 ± 10
days ofage.
Bodyweights at the start ofcohabitation
were not different, although during cohabi-
tation, feed consumption for the 0.15% P
groups was reduced by approximately 12%.
Primaclone consumption at 0.15% did not
alter the proportion ofpairs mating, becom-
ing pregnant, delivering a litter, or the
number of pups per litter, or their viability.
Pup weight adjusted for litter size was
reducedby4% in the P-treated mice.
After the F2 pups were delivered and
evaluated, the Fl adults were killed and
necropsied. Although male body weight
was not affected, liver weight adjusted for
body weight was increased by 43%, and
adjusted kidney weight was decreased by
12%, and seminal vesicle weight was
reduced by 14%. Epididymal sperm mea-
sures were unaffected by P consumption.
In females, bodyweight was not different
In summary, at these exposure concen-
trations, primaclone had no adverse effect
on reproductive end points in the first gen-
eration. Because liver weights were not col-
lected in the Fo mice, no conclusion can be
made as to the relative reproductive versus
somatic effects. In the second generation,
F2 pup body weight was reduced at an
exposure level that also changed parental
liver and kidney weights and lengthened
the estrous cycle. In other studies, this
degree ofadjusted body weight reduction
has been found to be related to female
treatment, not to male effects. Primaclone
was not found to be a selective reproductive
toxicant in this test.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB92128396
Chemical: Primaclone
CAS#: 125-33-7
Mode of exposure: Feed
Species/strain: Swiss CD-1 mice
F generation Dose concentration - 0.015% 0.05% 0.15%
Bodyweight _ ___
Kidneyweight8 e_
Liver w eighta
Mortality .. ____- -_- _=
Feed consumption
Water consumption
Clinical signs _-_ _-
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Rlitters/pair _
# livepups/litter; pupwt./litter - - - - - -
Cumulative days to litter 1'
Absolutetestis, epididymisweight8
Sex accessory glandweight' (prostate, seminalvesicle)
Epidid.spermparameters(#,motility, morphology) ..
Estrouscycle length * _
[Determination ofaffected sex(crossover) ] Male | Female r Both
[Doselevel j. j .. .. .*' - ' -'
F generation Dos concentration -.
.5...W EREElm~~~~~~~~~~~~~~~~~~~............................
Pupgrowth toweaning * _ - -
Mortality
Adult bodyweight . .
Kidneyweight' * 4
Liverweight' T . ,
Fedconsumption ._|_. _ 44
Waterconsumption . .
Clinical signs - - - -
Fertility index
#livepups/lifter, pupwt.litter * j *r
Absolutetestis, epididymisweight'
Sex accessoryglandweight'(prostate, seminal vesicle) - - - _1
Epidid. sperm parameters(i,motility, morphology) 1_
Estrous cycle length _ ;
Affected sex? Unclear
Studyconfounders: None
NOAELreproductivetoxicity: Fo>0.15%, F1 .0.15%
NOAEL generaltoxicity: <0.15%
F1 moresensitivethanF0? Yes
Postnataltoxicity: No
Legend: -, no change; *, no observation; 1 or41, statistically significant change (p<0.05);- , no change in males orfemales. 'Adjusted for bodyweight.
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